Renal safety of cisplatin;TOLERANCE RENALE DU CISPLATINE

Revue de Medecine Interne

Volumn 17, Issue 6, 1996, Pages 450-451

  Escudier, B ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

chemotherapy; cisplatinium; renal failure; toxicity

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

DRUG SAFETY; EDITORIAL; HUMAN; NEPHROTOXICITY; CHEMICALLY INDUCED DISORDER; KIDNEY DISEASE;

ANTINEOPLASTIC AGENTS; CISPLATIN; HUMANS; KIDNEY DISEASES;

EID: 0029904276     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)86435-6     Document Type: Article

References (13)

1. Bachmayer C Decroix Y Médioni J Coma, crise convulsive et troubles de l'oculomotricité hypomagnésémiques et hypocalcémiques après chimiothérapie par sels de platines Rev Méd Interne 17 1996 467 469
2. Brousse C Baumelou E Mignot L Hypocalcémie par hypomagnésémie au cours d'un traitement par cisplatine Rev Méd Interne 17 1996 498
3. (suppl) Brock PR Yeomans EC Bellman SC Pritchard J Cisplatin therapy in infants: short and long-term morbidity Br J Cancer 18 1992 36 40
4. Fossella FV Holoye P Winn R Phase II study of cis-platinum (P) + carboplatinum (CP) for extensive small cell lung cancer (SCLC) Proc Am Assoc Cancer Res 34 1993 A1226
5. Jabboury K Rogers L Ghaffir S Mangini O ICE-FL: a promising 7-day infusional regimen of ifosfamide (I) /mesna, cisplatin (C), etoposide (E), and 5-fluorouracil (F) /Leucovorin (L), in lung cancer Proc Am Soc Clin Oncol 12 1993 A1193
6. Mune T Yasuda K Ishii M Matsunaga T Miura K Tetany due to hypomagnesemia induced by cisplatin and doxorubicin treatment for synovial sarcoma Intern Med 32 1993 434 437
7. Leclercq B Escudier B Tandonnet F Conscience G Rossignol E Nitenberg G Pseudo-paralysie induite par la chimiothérapie anticancéreuse (cis-platinum) Cah Anesth 1 1985 23 24
8. Morris ME Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms Magnes Res 5 1992 303 313
9. Sartori S Nielsen I Tassinari D Rigolin F Abbasciano V Arcudi D Changes in intracellular magnesium concentrations during cisplatin chemotherapy Oncology 50 1993 230 234
10. Rodriguez M Solanki DL Whang R Refractory potassium repletion due to cisplatin-induced magnesium depletion Arch Intern Med 149 1989 2592 2594
11. Whang R Whang DD Ryan MP Refractory potassium repletion. A consequence of magnesium deficiency Arch Intern Med 152 1992 40 45
12. Evans TR Harper CL Beveridge IG Wastnage R Mansi JL A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cis platin chemotherapy with continuous infusion 5-fluorouracil Eur J Cancer 31A 1995 174 178
13. Martin M Diaz-Rubio E Casado A Lopez-Vega JM Sastre J Almenarez J Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trial Am J Clin Oncol 15 1992 348 351